期刊文献+

细胞焦亡与阿尔兹海默病及其中医药干预的研究进展 被引量:13

Research progresses and the effection of traditional Chinese medicine of pyroptosis and Alzheimer disease
下载PDF
导出
摘要 细胞焦亡是一种新发现的细胞程序性死亡方式,通过诱发炎症反应和破坏细胞膜完整性导致细胞死亡,近年来发现其与阿尔兹海默病的发病有密切关系:炎症小体可能参与β淀粉样蛋白的形成,其下游产物白细胞介素-1β和白细胞介素-18可能参与介导神经炎症反应,同时细胞焦亡导致神经元丢失。另外中医药可以有效干预细胞焦亡。研究细胞焦亡与阿尔兹海默病的关系有助于进一步阐明阿尔兹海默病的分子机制,为发现新的治疗靶点提供依据。 Pyroptosis is a new type of programmed cell death.Pyroptosis tightly controls inflammatory response and destroys cell membranes,which finally induces cell death.From the current knowledge of the role of pyroptosis in Alzheimer disease,we can see that there are several connections between pyroptosis and Alzheimer disease.Frist of all,Inflammasome might play a major role in triggering Amyloid plaques-clumps of protein accumulation.Second,pyroptosis might activate caspase-1 for the subsequent maturation of pro-inflammatory cytokines,IL-1βand IL-18,which could be implicated in the execution of inflammatory response.Third,pyroptosis leads to neuronal cell death which is associated with pathogenetic mechanisms in Alzheimer disease.The goal of this article is to discuss the connection between Pyroptosis and Alzheimer disease so to find out the new therapeutic strategies targeting Alzheimer Disease.
作者 黑鑫鑫 刘涛 HEI Xing-xing;LIU Tao(School of Basic Medical Sciences,Nanjing University of Chinese Medicine,Nanjing 210023,Jiangsu,China)
出处 《医学研究生学报》 CAS 北大核心 2018年第12期1319-1324,共6页 Journal of Medical Postgraduates
基金 国家自然科学基金(81173313)
关键词 NLRP1 NLRP3 阿尔兹海默病 中医药 NLRP1 NLRP3 Alzheimer disease traditional Chinese medicine
  • 相关文献

参考文献13

二级参考文献99

  • 1黄真,毛庆秋.雷公藤多甙的临床应用、不良反应及预防[J].药品评价,2005,2(2):125-128. 被引量:43
  • 2周泠,刘卓志.雷公藤多甙栓对溃疡性结肠炎大鼠TNF-a和IL-8的影响[J].遵义医学院学报,2006,29(1):31-33. 被引量:10
  • 3李燕舞,王汝俊,王建华,杜群,巫燕莉.补脾方药对脾虚大鼠壁细胞胃泌素受体及细胞内钙离子浓度的影响[J].中医杂志,2006,47(8):616-618. 被引量:4
  • 4Jack CR Jr, Knopman DS, Jagust WJ, et al. Tracking patho- physiological processes in Alzheimer's disease: an updated hypo- thetical modal of dynamic biomarkers[J]. Lancet Neurol, 2013, 12(2) : 207-216.
  • 5Villemagne VL, Burnham S, Bourgeat P, et al. Amyloid beta deposition, neurodegeneration and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study [J]. Lancet Neurol, 2013, 12(4): 357-367.
  • 6Hampel H, Frank R, Broich K, et al. Biomarkers for Alzheimer' s disease: academic, industry and regulatory perspectives [ J]. Nat Rev Drug Discov, 2010, 9(7) : 560-574.
  • 7Sperling RA, Jack CR Jr, Aisen PS. Testing the right target and right drug at the right stage [ J ]. Sci Transl Med, 2011, 3 (111): 111 end3.
  • 8McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzhcimcr's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer' s disease [ J ]. Neurology, 1984, 34(7) : 939-944.
  • 9Dubois B, Feldman HH, Jaeova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADR- DA criteria[J]. Lancet Neurol, 2007, 6(8) : 734-746.
  • 10Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer' s disease : a new lexicon [ J ]. Lancet Neurol, 2010, 9(11) : 1118-1127.

共引文献145

同被引文献147

引证文献13

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部